Dosing regimens associated with extended release paliperidone injectable formulations

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12208100
APP PUB NO 20230105276A1
SERIAL NO

17738422

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN PHARMACEUTICA NV

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gopal, Srihari Belle Mead, US 25 87
T'Jollyn, Huybrecht Ghent, BE 4 9
Venkatasubramanian, Raja Newtown, US 4 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 28, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 28, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 28, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00